Status: Recruiting
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes
Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Matthias GrieseUpdated: Sep 21, 2022Locations: 3Duration: 10 Years
Eligibility criteria
all children with suspected or [+3]
other indication as inclusion criteria